The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127646122 12764612 2 F 20160913 20160915 20160920 20160928 EXP FR-TAKEDA-2016MPI008190 TAKEDA 55.00 YR M Y 86.00000 KG 20160928 MD FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127646122 12764612 1 PS VELCADE BORTEZOMIB 1 Subcutaneous 1.3 MG/M2, UNK 21602 1.3 MG/M**2 INJECTION
127646122 12764612 2 SS DEXAMETHASONE. DEXAMETHASONE 1 Oral 20 MG, QD 0 20 MG QD
127646122 12764612 3 SS DARATUMUMAB DARATUMUMAB 1 Intravenous (not otherwise specified) 16 MG/KG, UNK 0 16 MG/KG
127646122 12764612 4 SS THALIDOMIDE THALIDOMIDE 1 Oral 100 MG, QD 11000 MG 0 100 MG QD
127646122 12764612 5 C FERRO-SEQUELS 2 Unknown UNK D 0
127646122 12764612 6 C MOVICOL POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE 1 Unknown UNK D 0
127646122 12764612 7 C AMLODIPINE AMLODIPINE BESYLATE 1 Unknown 6 MG, QD D 0 6 MG CAPSULE QD
127646122 12764612 8 C OXYNORM OXYCODONE HYDROCHLORIDE 1 Unknown UNK D 0
127646122 12764612 9 C MICROLAX /00285401/ 2 Unknown UNK D 0
127646122 12764612 10 C ZOFRAN ONDANSETRON HYDROCHLORIDE 1 Unknown UNK D 0
127646122 12764612 11 C OXYCONTIN OXYCODONE HYDROCHLORIDE 1 Oral 10 MG, BID D 0 10 MG TABLET BID
127646122 12764612 12 C KARDEGIC ASPIRIN LYSINE 1 Unknown 75 MG, QD D 0 75 MG QD
127646122 12764612 13 C WELLVONE ATOVAQUONE 1 Unknown 760 MG, BID D 0 760 MG BID
127646122 12764612 14 SS ROXITHROMYCIN ROXITHROMYCIN 1 Unknown 150 MG, QD D 0 150 MG TABLET QD
127646122 12764612 15 SS RANITIDINE. RANITIDINE 1 Unknown 150 MG, BID D 0 150 MG TABLET BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127646122 12764612 1 Plasma cell myeloma
127646122 12764612 2 Plasma cell myeloma
127646122 12764612 3 Plasma cell myeloma
127646122 12764612 4 Plasma cell myeloma
127646122 12764612 5 Haematotoxicity
127646122 12764612 6 Constipation
127646122 12764612 7 Hypertension
127646122 12764612 8 Bone pain
127646122 12764612 9 Constipation
127646122 12764612 10 Nausea
127646122 12764612 11 Bone pain
127646122 12764612 12 Thrombosis

Outcome of event

Event ID CASEID OUTC COD
127646122 12764612 HO
127646122 12764612 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127646122 12764612 Constipation
127646122 12764612 Nausea
127646122 12764612 Pyrexia
127646122 12764612 Varicella

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127646122 12764612 1 20160527 0
127646122 12764612 2 20160527 0
127646122 12764612 3 20160527 0
127646122 12764612 4 20160527 20160916 0
127646122 12764612 9 20160603 0
127646122 12764612 10 20160603 0
127646122 12764612 11 20160701 0
127646122 12764612 12 20160527 0